Skip to content
2000
Volume 17, Issue 4
  • ISSN: 1574-8863
  • E-ISSN: 2212-3911

Abstract

Background: Pregabalin is used in the treatment of neuropathic pain of various etiologies and as an adjuvant in epilepsy. Blockade of the α2δ subunit of L and N-type Ca-channels is its main mechanism of neurotropic action. Compared to other antiepileptics like phenytoin, valproate and lamotrigine, and other neuropathic pain medications such as amitriptyline and duloxetine, pregabalin has a relatively favorable safety profile and hence is a drug of choice for many geriatricians. Case Presentation: Here we describe a case of maculopapular rash induced by pregabalin in an older man, which resolved with withdrawal of the offending drug and conservative management. Conclusion: We have also conducted a literature review of similar cases and highlighted the clinical patterns and management strategies for pregabalin-induced skin rashes.

Loading

Article metrics loading...

/content/journals/cds/10.2174/1574886317666220309143913
2022-11-01
2024-12-26
Loading full text...

Full text loading...

/content/journals/cds/10.2174/1574886317666220309143913
Loading

  • Article Type:
    Case Report
Keyword(s): Anticonvulsant; dermatology; idiosyncratic; Pregabalin; rash; skin
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test